This year, all of the Group’s affiliates, employees, communities and the company’s partners will be attending a virtual edition of the event to confirm Chiesi’s commitment towards people, the community and the environment.
Parma, 24th September 2020 – Chiesi Farmaceutici, an international research-focussed pharmaceutical group (the Chiesi Group), is once again preparing to celebrate We ACT Day: We Actively Care for Tomorrow, which falls during the global mobilisation week dedicated to climate change. “We Act” is a term coined by Chiesi in 2018 for its own programme aimed at raising awareness and involving all of its employees to develop a more conscious way of behaving, so as to generate a positive impact on society and the environment.
We ACT Day (24th-25th September) will be held throughout all of the group’s 29 affiliates and will involve employees, institutional representatives from the area and the academic world and also associations. September the 25th was the date chosen as it coincides with the anniversary of the creation of the 17 Sustainable Development Goals (SDGs), which Chiesi has also adopted by committing to 9 of the goals it believes it can make the most significant contribution to.
The 2020 edition will be held via Live Streaming for all of Chiesi’s employees in Italy but will be celebrated across the rest of the Group with local projects. This is so that it will comply with the restrictions currently in place for the Covid-19 pandemic.
“In spite of the difficulties we have had to face over recent months due to the pandemic, I am delighted to once again celebrate We Act Day. It is a significant moment for our Company, particularly as it is a Benefit Company and certified B Corp committed year-round to creating wellbeing for people, society and the planet - comments Maria Paola Chiesi, Shared Value & Sustainability Head of the Chiesi Group -. A two-day event, this year in virtual format dedicated to an exchange of ideas and best practices between colleagues but also guest speakers from outside the company, whose important contributions will further the continuing improvement of our activities. Because let us not forget that people have always been and will continue to be the key figures in our development process”.There are four sessions relating to issues closely linked to the sustainability programme which Chiesi has introduced over the years: Community, Carbon Neutrality, Diversity & Inclusion (D&I) and Patients.
The Community session will address this year’s health and social emergency and the path to recovery, an issue which is especially significant in light of “Parma Capital for Culture 2020 + 21”. It will be a journey through the city of Parma and the local province to get to know the institutions and organisations that have been on the front line during the Covid-19 emergency. In addition, we will discover and enhance the value of the chemical-pharmaceutical identity of the Parma community, a cultural wealth which intertwines with the Group’s past and present.
Discussions will then move on to Diversity & Inclusion, two words which pave the way for a new way of interpreting work. With the help of Valentina Dolciotti, editor and founder of DiverCity Magazine, we will analyse the real meaning of D&I, focussing on Chiesi’s diversities, female leadership and generational differences.
In 2019 Chiesi announced its intention of achieving carbon neutrality by the end of 2035. In this year’s edition of We Act Day, a session will therefore also be dedicated to Environment & Carbon Neutrality, to gain an in-depth understanding of issues relating to environmental sustainability and energy policies, along with a series of best practices aimed at Carbon Neutrality.
Lastly, we will look at patients, the main target of Chiesi’s activities and mission to improve their quality of life every day. The Group’s therapeutic areas will be examined through the testimony of patients, business partners, associations and carers. At the end of the event the Chiesi Empathy Manifesto was launched to emphasise the central role patients play for the company.
The Chiesi Group
Based in Parma, Italy, Chiesi Farmaceutici is an international research-oriented group with 85 years’ experience in the pharmaceutical sector, operating in 29 countries. The Group conducts research and develops and markets innovative drugs for respiratory treatment, Special Care medicine and rare diseases. The Group’s Research and Development Centre is based in Parma and is integrated with 5 other important R&D centres in France, the USA, Canada, the UK and Sweden to promote its own pre-clinical, clinical and registration programmes. The Group employs around 6,000 people. Chiesi is a certified B Corp.
Contacts for the press:
Senior Global Communication Manager
Tel: +39 348 7693 623
Global Communication Manager
Tel: +39 339 5897483